The process of discovery and development of a molecule is complex, long and costly. Before making a decision on the offer that best meets your needs, we offer online scientific resources and our latest news to help you get to know us better. Our experts are also at your disposal to help and support you in your research and development program.
Filter by category
- All
- Blog
- Congress
- Scientific resource
- Webinar
- Poster
- Scientific publication
- Press release
- Press coverage
- News
Filter by category
Blog
23/04/2026
Why Don’t Biomarkers Reliably Reflect Clinical Translatability in Inflammation?
Biological activity doesn’t always translate. Discover why functional readouts are critical in preclinical inflammation research.
Poster
22/04/2026
Metastatic Prostate Tumor Model Development and Follow-Up Progression Using Imaging
Modeling late-stage prostate cancer metastasis to improve preclinical assessment of therapeutic candidates in clinically relevant settings.
Poster
21/04/2026
Tools for Utilization of Micro-Organisms as New Therapeutic Weapons Against Cancer
From infection to immune activation: preclinical tools to assess oncolytic viruses and bacteria in clinically relevant cancer models.
Poster
20/04/2026
In Vitro and In Vivo Strategies for Antibody Drug Conjugate Development
Advancing ADC development through integrated preclinical tools, from binding and internalization assays to translational efficacy models.
Poster
20/04/2026
Enhancing Preclinical Insights in Immuno-Oncology with Humanized Mice
Humanized mouse models as a bridge to the clinic, enabling translational assessment of immune-oncology drug candidates.
Blog
14/04/2026
A Closer Look at Astatine-211 in Targeted Alpha Radiotherapy
Understanding astatine-211 in targeted alpha radiotherapy, from high LET precision to radiochemistry, supply, and study design constraints.
Press release
13/04/2026
Oncodesign Services extends collaboration with GIP ARRONAX to strengthen At-211 supply
Oncodesign Services extends its collaboration with GIP ARRONAX to secure access to astatine-211 for targeted radiotherapy programs.
Blog
02/03/2026
Designing Robust In Vivo Bioluminescence Imaging Studies
Why substrate choice matters in bioluminescence imaging. Discover how study design decisions shape sensitivity, data quality, and biological insight.
Blog
02/03/2026
The Complexity Behind Modeling Endometriosis
Why is endometriosis so difficult to model preclinically? The biological and translational challenges behind the data.
Blog
27/02/2026
Functional Readouts as a Bridge Between Inflammation and Patient Experience
Why inflammation research must look beyond lesions to functional impact, with insights from dermatology, lung disease, and endometriosis.
Blog
24/02/2026
Alpha or Beta? Choosing the Right Emitter for Targeted Radiotherapy
What distinguishes alpha and beta emitters in targeted radiotherapy? How radiation range, LET, and radionuclide properties influence efficacy and development.
Blog
28/01/2026
Predicting Clinical Success in Preclinical Inflammatory Gut Disease Research
Insights into preclinical study design for inflammatory gut disease, covering acute vs chronic models, dosing strategies, and clinically relevant endpoints.